sglt2 inhibitors and glp 1 agonist Blood Pressure-Lowering Effects of GLP-1 Receptor Agonists | Current Hypertension Reports Combining GLP-1 Receptor Agonists and
Description
These variants relate to baseline weight-gain susceptibility and metabolic flexibility, informing which non-GLP-1 mechanisms may align with an individual's biological profile

Keep in mind, too, that most of these studies were done with people with type 2 diabetes , and werent on weight loss specifically
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
Takeda H, Sasai N, Ito S, et al
[PubMed] [Google Scholar] 31.Fair Health: Obesity and GLP-1 Drugs: A Claims-Based Analysis

Anyone with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not take GLP 1 medications

Aging parents, career demands, kids, relationship challenges
